Data as of Dec 11
| -7.19 / -2.52%|
The 24 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 288.00, with a high estimate of 367.00 and a low estimate of 236.00. The median estimate represents a +3.58% increase from the last price of 278.04.
The current consensus among 28 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.